Insider · CIK 0001517790
Suzanne Louise Bruhn
director
Files at TVTX (Travere Therapeutics, Inc.), PLRX (PLIANT THERAPEUTICS, INC.), DFTX (Definium Therapeutics, Inc.), VIGL (Vigil Neuroscience, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Common Stock | -5,000 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -24,073 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -18,068 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -33,875 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -13,928 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -24,310 | - | - | 0 | Aug 5, 2025 |
| Aug 5, 2025 | VIGL Vigil Neuroscience, Inc. | DDisposition to issuer Stock Option Award (Right to Buy)derivative | -6,235 | - | - | 0 | Aug 5, 2025 |
| Jun 12, 2025 | DFTX Definium Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +75,187 | $0.00 | $0 | 75,187 | Jun 16, 2025 |
| Jun 5, 2025 | PLRX PLIANT THERAPEUTICS, INC. | AGrant or award Common Stock (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 9, 2025 |
| May 22, 2025 | VIGL Vigil Neuroscience, Inc. | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 5,000 | May 23, 2025 |
| May 15, 2025 | TVTX Travere Therapeutics, Inc. | AGrant or award Common Stock | +6,500 | $0.00 | $0 | 28,750 | May 16, 2025 |
| May 15, 2025 | TVTX Travere Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +19,500 | $0.00 | $0 | 19,500 | May 16, 2025 |
| Mar 3, 2025 | VIGL Vigil Neuroscience, Inc. | AGrant or award Stock Option Award (Right to Buy)derivative | +33,875 | $0.00 | $0 | 33,875 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.